MARC Record from marc_columbia

LEADER: 09475pam a22004454a 4500
001 5017749
005 20221109205828.0
008 040813t20052005paua b 001 0 eng
010 $a 2004019274
015 $aGBA467382$2bnb
016 7 $a101226980$2DNLM
016 7 $a012992314$2Uk
020 $a0781734746
024 $aR3-469464
035 $a(OCoLC)OCM56214178
035 $a(NNC)5017749
035 $a5017749
040 $aDNLM/DLC$cDLC$dYDX$dNLM$dUKM$dC#P$dOrLoB-B
042 $apcc
043 $an-us---
050 00 $aRC564$b.S826 2005
060 10 $aWM 270$bS941 2004
082 00 $a362.29$222
245 00 $aSubstance abuse :$ba comprehensive textbook /$ceditors, Joyce H. Lowinson [and others].
250 $a4th ed.
260 $aPhiladelphia, Pa. :$bLippincott Williams & Wilkins,$c[2005], ©2005.
300 $axxiv, 1421 pages :$billustrations ;$c29 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $g1.$tHistorical perspectives /$rDavid F. Musto -- $g2.$tEpidemiology /$rCharles Winick and R. L. Norman -- $g3.$tU.S. federal drug policy /$rMathea Falco -- $g4.$tGenetic factors in the risk for substance use disorders /$rShow W. Lin and Robert M. Anthenelli -- $g5.$tBrain-reward mechanisms /$rEliot L. Gardner -- $g6.$tPsychodynamics /$rEdward J. Khantzian, Lance Dodes and Nancy M. Brehm -- $g7.$tSociocultural issues /$rBruce D. Johnson and Andrew Golub -- $g8.$tAlcohol : neurobiology /$rStephen L. Boehm II, C. Fernando Valenzuela and R. Adron Harris -- $g9.$tAlcohol : clinical aspects /$rBankole A. Johnson and Nassima Ait-Daoud -- $g10.$tOpiates : neurobiology /$rEric J. Simon -- $g11.$tOpiates : clinical aspects /$rClifford M. Knapp, Domenic A. Ciraulo and Jerome Jaffe -- $g12.$tCocaine and crack : neurobiology /$rMartin Repetto and Mark S. Gold -- $g13.$tCocaine and crack : clinical aspects /$rMark S. Gold and William S. Jacobs -- $g14.$tThe neurobiology of marijuana /$rSandra P. Welch -- $g15.$tMarihuana : clinical aspects /$rLester Grinspoon, James B. Bakalar and Ethan Russo -- $g16.$tAmphetamines and other stimulants /$rGeorge R. King and Everett H. Ellinwood, Jr. -- $g17.$tSedative-hypnotics /$rDonald R. Wesson, David E. Smith, Walter Ling and Richard B. Seymour -- $g18.$tHallucinogens /$rRobert N. Pechnick and J. Thomas Ungerleider -- $g19.$tPhencyclidine (PCP) /$rStephen R. Zukin, Zili Sloboda and Daniel C. Javitt -- $g20.$tInhalants /$rCharles W. Sharp and Neil L. Rosenberg -- $g21.$tDesigner drugs /$rJohn P. Morgan -- $g22.$tMDMA /$rCharles S. Grob and Russell E. Poland -- $g23.$tNicotine /$rJoy M. Schmitz and Katherine A. DeLaune -- $g24.$tCaffeine /$rLaura M. Juliano and Roland R. Griffiths -- $g25.$tAnabolic-androgenic steroids /$rElyse R. Eisenberg and Gantt P. Galloway -- $g26.$tPrescription opiate abuse /$rWalter Ling, Donald R. Wesson and David E. Smith -- $g27.$tEating disorders /$rMark S. Gold and Jodi Star -- $g28.$tPathologic gambling /$rSheila B. Blume and Hermano Tavares -- $g29.$tAddiction and cults : synthesizing a model for treating ex-members /$rRon Burks -- $g30.$tSexual addiction : nosology, diagnosis, etiology, and treatment /$rAviel Goodman -- $g31.$tInternet/computer addiction /$rZebulon Taintor -- $g32.$tCollecting, accumulation, and hoarding : acquisitions and their discontents /$rDavid A. Halperin and Jane Glick -- $g33.$tDiagnosis and classification : DSM-IV-TR and ICD-10 /$rJohn Cacciola and George E. Woody -- $g34.$tDiagnostic laboratory : screening for drug abuse /$rKarl G. Verebey, Gerard Meenan and Betty J. Buchan -- $g35.$tDetoxification /$rGrace Chang and Thomas R. Kosten -- $g36.$tAlcoholics Anonymous /$rEdgar P. Nace -- $g37.$tAlternative support groups /$rArthur T. Horvath -- $g38.$tThe therapeutic community /$rWilliam B. O'Brien and Fernando B. Perfas -- $g39.$tMethadone maintenance /$rJoyce H. Lowinson, Ira Marion, Herman Joseph, John Langrod, Edwin A. Salsitz, J. Thomas Payte and Vincent P. Dole -- $g40.$tBuprenorphine for the treatment of opioid addiction /$rPaul J. Fudala and Charles P. O'Brien -- $g41.$tAlternative pharmacotherapies for opioid addiction /$rPaul J. Fudala, Robert A. Greenstein and Charles P. O'Brien -- $g42.$tIndividual psychotherapy /$rBruce J. Rounsaville, Kathleen M. Carroll and Sudie Back -- $g43.$tGroup therapy with outpatients /$rArnold M. Washton -- $g44.$tFamily/couples approaches to treatment engagement and therapy /$rM. Duncan Stanton and Anthony W. Heath -- $g45.$tThe role of coercion in drug treatment /$rSally L. Satel and David J. Farabee -- $g46.$tTreatment in prisons and jails /$rRoger H. Peters, Charles O. Matthews and Joel A. Dvoskin -- $g47.$tCognitive and behavioral therapies /$rLisa M. Najavits, Bruce S. Liese and Melanie S. Harned -- $g48.$tNetwork therapy /$rMarc Galanter -- $g49.$tAcupuncture /$rJi-Sheng Han, Alan I. Trachtenberg and Joyce H. Lowinson -- $g50.$tFaith-based approaches /$rJohn G. Langrod, John Muffler, James Abel, James T. Richardson, Eugenia Curet, Herman Joseph and Pedro Ruiz -- $g51.$tRelapse prevention /$rDennis C. Daley and G. Alan Marlatt -- $g52.$tEvaluation and outcome of treatment /$rRobert L. Hubbard -- $g53.$tMaternal and neonatal effects of alcohol and drugs /$rLoretta P. Finnegan and Stephen R. Kandall -- $g54.$tMedical complications of drug use /$rMarc N. Gourevitch and Julia H. Arnsten -- $g55.$tAcute and chronic pain /$rRussell K. Portenoy, Richard Payne and Steven D. Passik -- $g56.$tSubstance use disorders in individuals with co-occurring psychiatric disorders /$rSylvia J. Dennison -- $g57.$tEpidemiology and emerging public health perspectives /$rDon C. Des Jarlais, Holly Hagan and Samuel R. Friedman -- $g58.$tHIV-related medical complications and treatment /$rChinazo O. Cunningham and Peter A. Selwyn -- $g59.$tNeuropsychiatric aspects of HIV-1 infection /$rFrancisco Fernandez, Jorge Maldonado and Pedro Ruiz -- $g60.$tPsychosocial issues of HIV/AIDS among drug users in treatment /$rJames L. Sorensen, Nancy A. Haug and Steven L. Batki -- $g61.$tChildren of substance-abusing parents /$rPatti Juliana and Carolyn Goodman -- $g62.$tAdolescents /$rAndres J. Pumariega, Mark D. Kilgus and Leonardo Rodriguez -- $g63.$tThe elderly /$rSteven R. Gambert and Charles R. Albrecht III -- $g64.$tAlcohol and women /$rSheila B. Blume and Monica L. Zilberman -- $g65.$tDrugs and women /$rMonica L. Zilberman and Sheila B. Blume -- $g66.$tWomen's research and policy issues /$rMarsha Rosenbaum and Sheigla Murphy -- $g67.$tAfrican Americans : epidemiology, prevention, and treatment issues /$rCharles Madray, Lawrence S. Brown, Jr. and Beny J. Primm -- $g68.$tHispanic Americans /$rPedro Ruiz and John G. Langrod -- $g69.$tAsian Americans and Pacific Islanders /$rJohn W. Tsuang -- $g70.$tAlcohol use among American Indians and Alaskan natives /$rEdward F. Foulks -- $g71.$tGays, lesbians, and bisexuals /$rRobert Paul Cabaj -- $g72.$tThe homeless /$rHerman Joseph and John Langrod -- $g73.$tDisability and rehabilitation issues /$rAllen W. Heinemann and Purva H. Rawal -- $g74.$tPhysicians and other health professionals /$rG. Douglas Talbott and Philip O. Wilson -- $g75.$tNew immigrants and refugees /$rJoseph Westermeyer -- $g76.$tSchool-based programs /$rGilbert J. Botvin and Kenneth W. Griffin -- $g77.$tHarm reduction : pragmatic drug policies for public health and safety /$rErnest Drucker, Ethann Nadelman, Robert G. Newman, Alex Wodak, Jennifer McNeely, Kasia Malinowska-Semprucht, David Marsh, Martin Schechter, Bruna Brands and Eugene Oscapella -- $g78.$tChurch, family, and community in the prevention and treatment of addiction among African Americans /$rRonald Hopson and William B. Lawson -- $g79.$tThe public health approach to the prevention of substance abuse /$rSteven Jonas -- $g80.$tMedical education in substance abuse : the acquisition of knowledge, attitudes, and skills /$rJohn N. Chappel -- $g81.$tEducation and training of clinical personnel /$rDavid A. Deitch, Igor Koutsenok and Karin Marsolais -- $g82.$tForensics /$rMilton Earl Burglass and Stuart Gitlow -- $g83.$tThe role of neuropsychological assessment in forensic addiction /$rAri D. Kalechstein, Wilfred G. van Gorp and Garrett J. Zelen -- $g84.$tA new era for methadone advocacy /$rJoycelyn Woods, Walter Ginter and Tony Scro -- $g85.$tThe workplace /$rPaul F. Engelhart and Linda Barlow -- $g86.$tTreatment for alcohol and drug dependence : history, workforce, organization, financing, and emerging policies /$rDennis McCarty and Howard H. Goldman -- $g87.$tLegal aspects of confidentiality of patient information /$rMargaret K. Brooks -- $g88.$tClinical and societal implications of drug legalization /$rHerbert D. Kleber and James A. Inciardi.
650 0 $aSubstance abuse.$0http://id.loc.gov/authorities/subjects/sh85129539
650 0 $aSubstance abuse$xTreatment.$0http://id.loc.gov/authorities/subjects/sh97001424
650 0 $aSubstance abuse$xSocial aspects.$0http://id.loc.gov/authorities/subjects/sh2010114985
650 0 $aSubstance abuse$zUnited States.$0http://id.loc.gov/authorities/subjects/sh2010113419
650 12 $aSubstance-Related Disorders.$0https://id.nlm.nih.gov/mesh/D019966
700 1 $aLowinson, Joyce H.$0http://id.loc.gov/authorities/names/n77011270
856 41 $3Table of contents$uhttp://www.loc.gov/catdir/toc/ecip0421/2004019274.html
852 00 $boff,hsl$hRC564$i.Su1 2005 Q
852 00 $bswx$hRC564$i.S826 2005